FN2 Earnings Intelligence
Xylem Inc. ratios
Xylem Inc. (XYL) Ratios (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,349 | $944 | $1,019 | $1,121 | $1,479 | - | - |
| + Debt | $2,440 | $1,880 | $2,284 | $2,016 | $1,942 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $5,195 | $5,522 | $7,364 | $8,562 | $9,035 | $9,205.7 | $9,566.2 |
| % Growth | 6.5% | 6.3% | 33.4% | 16.3% | 5.5% | 1.9% | 3.9% |
| Gross Profit | $1,975 | $2,084 | $2,717 | $3,212 | $3,475 | - | - |
| % Margin | 38.0% | 37.7% | 36.9% | 37.5% | 38.5% | - | - |
| EBITDA | $830 | $858 | $1,088 | $1,571 | $1,798 | - | - |
| % Margin | 16.0% | 15.5% | 14.8% | 18.3% | 19.9% | - | - |
| Net Income | $427 | $355 | $609 | $890 | $957 | - | - |
| % Margin | 8.2% | 6.4% | 8.3% | 10.4% | 10.6% | - | - |
| Diluted EPS | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 | $5.63 | $6.18 |
| % Growth | 67.9% | -16.6% | 42.3% | 30.8% | 7.4% | 43.7% | 9.6% |
| Operating Cash Flow | $538 | $596 | $837 | $1,263 | $1,241 | - | - |
| CapEx | $208 | $208 | $271 | $321 | $331 | - | - |
| Free Cash Flow | $330 | $388 | $566 | $942 | $910 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $5,195 | $5,522 | $7,364 | $8,562 | $9,035 | $9,205.7 | $9,566.2 |
| Gross Profit | $1,975 | $2,084 | $2,717 | $3,212 | $3,475 | - | - |
| EBITDA | $830 | $858 | $1,088 | $1,571 | $1,798 | - | - |
| Net Income | $427 | $355 | $609 | $890 | $957 | - | - |
| Diluted EPS | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 | $5.63 | $6.18 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,349 | $944 | $1,019 | $1,121 | $1,479 |
| Short-term Debt | $0 | $0 | $16 | $38 | $534 |
| Long-term Debt | $2,440 | $1,880 | $2,268 | $1,978 | $1,408 |
| Total Debt | $2,440 | $1,880 | $2,284 | $2,016 | $1,942 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $538 | $596 | $837 | $1,263 | $1,241 |
| Capital Expenditure | $208 | $208 | $271 | $321 | $331 |
| Free Cash Flow | $330 | $388 | $566 | $942 | $910 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 6.5% | 6.3% | 33.4% | 16.3% | 5.5% |
| Gross Margin | 38.0% | 37.7% | 36.9% | 37.5% | 38.5% |
| EBITDA Margin | 16.0% | 15.5% | 14.8% | 18.3% | 19.9% |
| Net Margin | 8.2% | 6.4% | 8.3% | 10.4% | 10.6% |
| FCF Margin | 6.4% | 7.0% | 7.7% | 11.0% | 10.1% |
| Diluted EPS Growth | 67.9% | -16.6% | 42.3% | 30.8% | 7.4% |